| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |